Glaxo Lotronex Studies May Expand Market To Men, Teens, Pediatrics

Glaxo will try to expand the Lotronex (alosetron) market to men, adolescents and children, following the Feb. 9 approval of the irritable bowel syndrome treatment for use in women whose predominant IBS symptom is diarrhea.